Todo, Maki
Gatate, Yodo
Nakano, Shintaro
Kaneko, Go
Hagiwara, Masayuki
Takahashi, Takayuki
Umezawa, Yuta
Ueda, Genji
Ishikawa, Shiho
Makino, Yoshinori
Oyama, Masafumi
Shirotake, Suguru
Article History
Received: 14 September 2024
Accepted: 15 January 2025
First Online: 4 February 2025
Declarations
:
: S. Shirotake has received lecture fees from Ono Pharmaceutical, Bristol Myers Squibb. The other authors have no conflicts of interest for this article.
: The present study was approved by the Clinical Ethics Committee at the International Medical Center, Saitama Medical University (approval no. 2024-005) and followed the standards of the Declaration of Helsinki and the ethical standards of the responsible committee on human experimentation.